Advanced search
Publication Cover
OncoImmunology Volume 9, 2020 - Issue 1
Submit an article Journal homepage
2,323
Views
15
CrossRef citations to date
0
Altmetric
Original Research

Angiotensin-converting enzyme (ACE) inhibitor prescription affects non-small-cell lung cancer (NSCLC) patients response to PD-1/PD-L1 immune checkpoint blockers

Soleine Medjebara Department of Medical Oncology, GF Leclerc Centre, Dijon, France;b Platform of Transfer in Cancer Biology, GF Leclerc Centre, Dijon, FranceView further author information
,
Caroline Truntzerb Platform of Transfer in Cancer Biology, GF Leclerc Centre, Dijon, France;c University of Bourgogne-Franche-Comté, Dijon, France;d Genetic and Immunology Medical Institute (GIMI), Dijon, France;e INSERM UMR1231, Dijon, FranceView further author information
,
Anaïs Perrichetb Platform of Transfer in Cancer Biology, GF Leclerc Centre, Dijon, France;c University of Bourgogne-Franche-Comté, Dijon, France;e INSERM UMR1231, Dijon, FranceView further author information
,
Emeric Limagneb Platform of Transfer in Cancer Biology, GF Leclerc Centre, Dijon, France;c University of Bourgogne-Franche-Comté, Dijon, France;e INSERM UMR1231, Dijon, FranceView further author information
,
Jean-David Fumeta Department of Medical Oncology, GF Leclerc Centre, Dijon, France;b Platform of Transfer in Cancer Biology, GF Leclerc Centre, Dijon, France;c University of Bourgogne-Franche-Comté, Dijon, FranceView further author information
,
Corentin Richardb Platform of Transfer in Cancer Biology, GF Leclerc Centre, Dijon, France;c University of Bourgogne-Franche-Comté, Dijon, FranceView further author information
,
Arielle Elkrieff Research Centre for the University of Montréal (CRCHUM), Montréal. Hematology-Oncology Division, Department of Medicine, University of Montreal Healthcare Centre (CHUM), Montreal, CanadaView further author information
,
Bertrand Routyf Research Centre for the University of Montréal (CRCHUM), Montréal. Hematology-Oncology Division, Department of Medicine, University of Montreal Healthcare Centre (CHUM), Montreal, CanadaView further author information
,
Cédric Rébéb Platform of Transfer in Cancer Biology, GF Leclerc Centre, Dijon, France;c University of Bourgogne-Franche-Comté, Dijon, France;e INSERM UMR1231, Dijon, FranceView further author information
&
François Ghiringhellia Department of Medical Oncology, GF Leclerc Centre, Dijon, France;b Platform of Transfer in Cancer Biology, GF Leclerc Centre, Dijon, France;c University of Bourgogne-Franche-Comté, Dijon, France;d Genetic and Immunology Medical Institute (GIMI), Dijon, France;e INSERM UMR1231, Dijon, FranceCorrespondence[email protected]
View further author information
 show all
Article: 1836766 | Received 26 Feb 2020, Accepted 10 Oct 2020, Published online: 27 Oct 2020

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.